Trulicity 1.5Mg 4 Pre-Filled Pens

Trulicity 1.5 mg Injection Pens (Dulaglutide) – 4 Prefilled Pens

Drug Overview

Trulicity 1.5 mg is a once-weekly injectable medication used to improve blood glucose control in adults with type 2 diabetes mellitus. It contains dulaglutide, a GLP-1 receptor agonist that supports insulin secretion and helps regulate blood sugar levels. Trulicity 1.5 mg is commonly prescribed as part of a comprehensive diabetes management plan that includes diet, exercise, and lifestyle modification.

Active Ingredient and Composition

• Active ingredient: Dulaglutide
• Strength: 1.5 mg per prefilled pen
• Dosage form: Solution for subcutaneous injection
• Pack size: 4 prefilled injection pens

Dulaglutide is a long-acting incretin mimetic designed for once-weekly administration.

Drug Class

• GLP-1 Receptor Agonist (Glucagon-like peptide-1 analog)

Uses and Medical Indications of Trulicity 1.5 mg

Trulicity 1.5 mg is indicated for:

• Type 2 diabetes mellitus:
  • Improves glycemic control
  • Reduces HbA1c levels
• Cardiovascular risk reduction:
  • Helps lower the risk of major cardiovascular events in patients with diabetes and heart disease

It is not intended for type 1 diabetes or diabetic ketoacidosis.

How Trulicity 1.5 mg Works

Dulaglutide works by mimicking the natural GLP-1 hormone, leading to:

• Increased insulin secretion in response to meals
• Decreased glucagon release
• Slower gastric emptying
• Reduced appetite and potential weight loss

These mechanisms help stabilize blood sugar levels and improve metabolic control.

Dosage and Administration

• Administered once weekly via subcutaneous injection
• Inject into the abdomen, thigh, or upper arm
• Can be used with or without meals
• Should be used on the same day each week

Always follow your healthcare provider’s instructions regarding dose adjustments.

Possible Side Effects of Trulicity 1.5 mg

Common side effects:

• Nausea
• Diarrhea
• Vomiting
• Abdominal discomfort
• Decreased appetite

Serious but rare side effects:

• Pancreatitis (severe abdominal pain)
• Thyroid tumors (in animal studies)
• Severe allergic reactions

Seek medical attention if serious symptoms occur.

Contraindications

• History of hypersensitivity to dulaglutide
• Personal or family history of medullary thyroid carcinoma
• Patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Drug Interactions

Trulicity 1.5 mg may interact with:

• Oral medications affected by delayed gastric emptying
• Insulin or sulfonylureas (increased risk of hypoglycemia)

Inform your doctor about all medications and supplements.

Warnings and Precautions

• Monitor blood glucose levels regularly
• Use caution in patients with gastrointestinal disorders
• Monitor for signs of pancreatitis
• Not recommended in severe renal impairment without supervision

Use During Pregnancy and Breastfeeding

• Use only if clearly needed and prescribed
• Limited safety data in pregnancy
• Consult your doctor before breastfeeding

Use for Children

• Not approved for use in children under 18 years

Drug Alternatives

Other GLP-1 receptor agonists include:

• Semaglutide
• Liraglutide
• Exenatide

Treatment choice depends on patient profile and clinical goals.

Comparison With Similar Drugs

• Trulicity 1.5 mg offers once-weekly dosing convenience
• Effective for both glycemic control and weight reduction
• Similar efficacy to semaglutide but may differ in weight loss outcomes

Safe Usage Tips

• Rotate injection sites to avoid irritation
• Store pens in the refrigerator (do not freeze)
• Do not share injection pens
• Maintain a balanced diet and exercise routine

Conclusion

Trulicity 1.5 mg is an advanced GLP-1 receptor agonist that provides effective blood sugar control and cardiovascular benefits for patients with type 2 diabetes. With its convenient weekly dosing and metabolic advantages, it is a valuable option in modern diabetes management when used under medical supervision.